Tizanidine induced hypotension: report of a case and review of literature
CONCLUSION: This patient highlights the need for close monitoring of patients receiving tizanidine co-medication with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. These drugs have a synergistic effect on reducing the renin-angiotensin-aldosterone system, thereby hypotension and bradycardia.PMID:37489780 | DOI:10.2174/1574886318666230725113855
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Roopali Mahajan Jayantee Kalita Source Type: research
More News: Atenolol | Baclofen | Beta-Blockers | Chemistry | Diabetes | Drugs & Pharmacology | Endocrinology | Hemorrhagic Stroke | Hypertension | Norvasc | Physiotherapy | Reflex Sympathetic Dystrophy | Stroke | Tizanidine